Emerging Pharmaceutical Therapies to Address the Inadequacy of Gluten-Free Diet for Celiac Disease

Abstract excerpt

.Celiac disease (CeD) is a chronic, autoimmune disorder triggered by the ingestion of gluten, affecting around 1% of the global population. It is a multifactorial disease involving both genetics and environ-mental factors. Nowadays, the only available treatment for CeD is a life-long gluten-free diet (GFD), which can cause a significant burden for patients, since symptoms and mucosal injury can persist de-spite ap...

Topics

Open a Topic to create a Post that cites this publication.

• Celiac Disease
• Diet, Gluten-Free
• Drug Design
• Genetic Predisposition to Disease
• Glutens
• Quality of Life
• Transglutaminases
• Treatment Outcome

Identifiers and source

Literature Corpus work

442ff957-4602-5384-994b-4de6b656c8e8

DOI

10.20944/preprints202311.0285.v1